toggle navigation
HOME
ABOUT
Overview
History
Our Leadership
Our Advisors
Our Values
TECHNOLOGY
ATRIVIEW® CNS Drug Screening Platform
SHINE MOUSE® and NuvoMab™ Platform
Publications
PIPELINE
NEWS
News Release
Company Notice
CONTACT
LANGUAGE
KOREAN
ENGLISH
toggle navigation
HOME
ABOUT
Overview
History
Our Leadership
Our Advisors
Our Values
TECHNOLOGY
ATRIVIEW® CNS Drug Screening Platform
SHINE MOUSE® and NuvoMab™ Platform
Publications
PIPELINE
NEWS
News Release
Company Notice
CONTACT
LANGUAGE
KOREAN
ENGLISH
EN
|
KR
News
Title
GENUV, Receives Approval for ALS Phase 1·2a Clinical Studies
2019-09-19
Link :
https://www.mk.co.kr/news/home/view/2019/09/744320/
Prev
GENUV, Receives Approval for ALS Phase 1·2a Clinical Studies on New Drug "SNR1611"
Next
[2019 Korea Patent Award] GENUV ... Developing Treatments for Neurodegenerative Diseases with ATRIVIEW™ Technology
list
